International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI · May 2, 2022

Keywords

ClinConnect Summary

The i-RECORD Project is a clinical trial designed to study the best treatment options for patients with localized kidney tumors, which are cancerous growths in the kidney that are small enough to treat without removing the entire kidney. The trial will explore different management strategies, including partial nephrectomy (surgery to remove part of the kidney), ablation techniques (destroying the tumor without surgery), and options like watchful waiting or active surveillance, where doctors closely monitor the tumor without immediate treatment. The goal is to gather strong evidence that can help doctors make better decisions tailored to each patient's unique situation, including their age, health conditions, and the specifics of their tumor.

To participate in this trial, individuals must be at least 18 years old and have a diagnosed kidney tumor that might require treatment or careful observation. Participants will need to give their consent to be part of the study. Throughout the trial, they can expect to receive close monitoring and care, and their experiences will contribute to a better understanding of how different treatment options affect not only cancer outcomes but also quality of life over time. This research aims to fill gaps in current knowledge and improve future guidelines for managing kidney cancer effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Radiological diagnosis of renal tumor susceptible to active treatment or AS/WW.
• • Age ≥18 years
• • Informed consent signed
• Exclusion Criteria:
• • Patient refuse to participate in clinical research.
• • Urothelial renal carcinoma.